Development of a semi-defined medium supporting production of platensimycin and platencin by Streptomyces platensis

Sabrina Aluotto1, Heather Tynan, Christian Maggio

  • 1Charles A Dana Research Institute for Scientists Emerti, Drew University, Madison, NJ, USA.

The Journal of Antibiotics
|November 29, 2012
PubMed

Insights

Researchers developed a new soluble, semi-defined medium (PM5) for producing the promising antibacterial compounds platensimycin and platencin from Streptomyces platensis. This advancement aids in studying the biosynthetic pathway of these important antibiotics.

Area of Science:

  • Microbiology
  • Biochemistry
  • Natural Product Synthesis

Background:

  • Platensimycin and platencin are novel antibiotics with significant antibacterial activity.
  • These compounds are produced via fermentation by Streptomyces platensis.
  • The original production medium was crude, insoluble, and hindered further metabolic studies.

Purpose of the Study:

  • To develop a chemically-defined, soluble medium for optimal production of platensimycin and platencin.
  • To investigate the influence of primary metabolites and inorganic compounds on antibiotic biosynthesis.
  • To elucidate the precursors and biosynthetic pathway of these antibacterial agents.

Main Methods:

  • Development and testing of various media with different chemical definitions and solubilities.
  • Utilizing the original Merck medium as a baseline for optimization.
  • Assessing antibiotic production using agar diffusion assays, bioautography, and High-Performance Liquid Chromatography (HPLC).

Main Results:

  • A soluble, semi-defined medium (PM5) was successfully developed.
  • PM5 yielded suitable production of platensimycin and platencin.
  • Antibiotics were predominantly found in the extracellular broth, not within the microbial cells (mycelia).

Conclusions:

  • The developed PM5 medium is effective for producing platensimycin and platencin.
  • This chemically-defined medium facilitates future research into the biosynthesis of these antibiotics.
  • Understanding the production pathway can inform strategies for enhancing antibiotic yields.

Related Concept Videos

Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Scale-Up Processes01:14

Scale-Up Processes

The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Designing Growth Media for Bioreactors01:30

Designing Growth Media for Bioreactors

Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...